
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6678518
[patent_doc_number] => 20030228659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Novel angiopoietin materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/351161
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33131
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228659.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351161 | Novel angiopoietin materials and methods | Jan 23, 2003 | Abandoned |
Array
(
[id] => 5953832
[patent_doc_number] => 20110034381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH)'
[patent_app_type] => utility
[patent_app_number] => 10/502364
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11749
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502364 | Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH) | Jan 21, 2003 | Abandoned |
Array
(
[id] => 7409286
[patent_doc_number] => 20040024533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Method for node mapping, network visualizing and screening'
[patent_app_type] => new
[patent_app_number] => 10/346871
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5755
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20040024533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10346871
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/346871 | Method for node mapping, network visualizing and screening | Jan 20, 2003 | Abandoned |
Array
(
[id] => 6822322
[patent_doc_number] => 20030220483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/347177
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9297
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10347177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/347177 | Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use | Jan 15, 2003 | Abandoned |
Array
(
[id] => 6634876
[patent_doc_number] => 20030211575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Constituitively open voltage-gated kand methods for discovering modulators thereof'
[patent_app_type] => new
[patent_app_number] => 10/203578
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14313
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211575.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203578
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203578 | Constituitively open voltage-gated kand methods for discovering modulators thereof | Dec 26, 2002 | Abandoned |
| 10/321980 | Polynucleotides and polypeptides | Dec 16, 2002 | Abandoned |
Array
(
[id] => 6939721
[patent_doc_number] => 20050113284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Drug for regenerating tissue and vessel and method therefor'
[patent_app_type] => utility
[patent_app_number] => 10/498332
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 24819
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113284.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498332
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498332 | Drug for regenerating tissue and vessel and method therefor | Dec 11, 2002 | Abandoned |
Array
(
[id] => 566239
[patent_doc_number] => 07465704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF)'
[patent_app_type] => utility
[patent_app_number] => 10/499457
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4408
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499457 | Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF) | Dec 3, 2002 | Issued |
Array
(
[id] => 6634415
[patent_doc_number] => 20030211547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption'
[patent_app_type] => new
[patent_app_number] => 10/297269
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12286
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297269 | Large conductance calcium-dependent potassium channel as modulator of alcohol effects and consumption | Dec 1, 2002 | Abandoned |
Array
(
[id] => 6730180
[patent_doc_number] => 20030186370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => '5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof'
[patent_app_type] => new
[patent_app_number] => 10/203968
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10386
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186370.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203968 | 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof | Nov 25, 2002 | Abandoned |
Array
(
[id] => 6762161
[patent_doc_number] => 20030125523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Novel neuropilin/growth factor complexes and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/303786
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11248
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10303786
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/303786 | Soluble neuropilin/growth factor receptor fusion proteins | Nov 25, 2002 | Issued |
Array
(
[id] => 6660155
[patent_doc_number] => 20030134799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function'
[patent_app_type] => new
[patent_app_number] => 10/302971
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17787
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302971 | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function | Nov 24, 2002 | Abandoned |
Array
(
[id] => 6796881
[patent_doc_number] => 20030175755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Method of collecting data for estimation of susceptibility to periodontal disease'
[patent_app_type] => new
[patent_app_number] => 10/300799
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10524
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175755.pdf
[firstpage_image] =>[orig_patent_app_number] => 10300799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/300799 | Method of collecting data for estimation of susceptibility to periodontal disease | Nov 20, 2002 | Abandoned |
Array
(
[id] => 6642087
[patent_doc_number] => 20030103935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Soluble variants of type I membrane proteins, and methods of using them'
[patent_app_type] => new
[patent_app_number] => 10/299383
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9649
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20030103935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299383 | Soluble variants of type I membrane proteins, and methods of using them | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6702646
[patent_doc_number] => 20030225526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Molecular cancer diagnosis using tumor gene expression signature'
[patent_app_type] => new
[patent_app_number] => 10/294453
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10907
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20030225526.pdf
[firstpage_image] =>[orig_patent_app_number] => 10294453
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/294453 | Molecular cancer diagnosis using tumor gene expression signature | Nov 13, 2002 | Abandoned |
Array
(
[id] => 7313227
[patent_doc_number] => 20040033527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain'
[patent_app_type] => new
[patent_app_number] => 10/293992
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 372140
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033527.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293992 | Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain | Nov 12, 2002 | Abandoned |
Array
(
[id] => 6711018
[patent_doc_number] => 20030170767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Fluorescent protein sensors of post-translational modifications'
[patent_app_type] => new
[patent_app_number] => 10/293580
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20992
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293580
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293580 | Fluorescent protein sensors of post-translational modifications | Nov 11, 2002 | Abandoned |
Array
(
[id] => 951237
[patent_doc_number] => 06960439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-01
[patent_title] => 'Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles'
[patent_app_type] => utility
[patent_app_number] => 10/291225
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 47
[patent_no_of_words] => 27959
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/960/06960439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291225
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291225 | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles | Nov 7, 2002 | Issued |
Array
(
[id] => 6821610
[patent_doc_number] => 20030219771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles'
[patent_app_type] => new
[patent_app_number] => 10/291856
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 28312
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291856 | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles | Nov 7, 2002 | Issued |
Array
(
[id] => 6851517
[patent_doc_number] => 20030143720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'High throughput functional genomics'
[patent_app_type] => new
[patent_app_number] => 10/286760
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23728
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10286760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/286760 | High throughput functional genomics | Nov 3, 2002 | Abandoned |